Clinical Trial Update: A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC [Phase 2]

View source ↗

Summary

Phase 2 study LB-P8 in Primary Sclerosing Cholangitis is currently recruiting to assess safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• LB-P8

Snippet

Sponsor: LISCure Biosciences | Conditions: Primary Sclerosing Cholangitis (PSC) | Phase 2 | Status: RECRUITING